IONM vs. BIOL, SDCCQ, TTOO, GMVDF, VRAYQ, AFIB, SONX, NMRD, UTRS, and MOTS
Should you be buying Assure stock or one of its competitors? The main competitors of Assure include BIOLASE (BIOL), SmileDirectClub (SDCCQ), T2 Biosystems (TTOO), G Medical Innovations (GMVDF), ViewRay (VRAYQ), Acutus Medical (AFIB), Sonendo (SONX), Nemaura Medical (NMRD), Minerva Surgical (UTRS), and Motus GI (MOTS). These companies are all part of the "medical equipment" industry.
Assure vs. Its Competitors
BIOLASE (NASDAQ:BIOL) and Assure (NASDAQ:IONM) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their dividends, institutional ownership, profitability, valuation, analyst recommendations, media sentiment, risk and earnings.
BIOLASE has a beta of 0.67, suggesting that its share price is 33% less volatile than the S&P 500. Comparatively, Assure has a beta of 185.12, suggesting that its share price is 18,412% more volatile than the S&P 500.
BIOLASE has a net margin of -41.65% compared to Assure's net margin of -25,178.32%. Assure's return on equity of 0.00% beat BIOLASE's return on equity.
BIOLASE currently has a consensus price target of $0.40, suggesting a potential upside of 0.00%. Given BIOLASE's stronger consensus rating and higher probable upside, equities research analysts clearly believe BIOLASE is more favorable than Assure.
BIOLASE has higher revenue and earnings than Assure.
In the previous week, BIOLASE's average media sentiment score of 0.00 equaled Assure'saverage media sentiment score.
8.8% of BIOLASE shares are held by institutional investors. Comparatively, 3.3% of Assure shares are held by institutional investors. 0.3% of BIOLASE shares are held by company insiders. Comparatively, 3.8% of Assure shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.
Summary
BIOLASE beats Assure on 8 of the 11 factors compared between the two stocks.
Get Assure News Delivered to You Automatically
Sign up to receive the latest news and ratings for IONM and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding IONM and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Related Companies and Tools
This page (NASDAQ:IONM) was last updated on 9/5/2025 by MarketBeat.com Staff
